This gene belongs to the ubiquitin C-terminal hydrolase subfamily of deubiquitinating enzymes that are involved in the removal of ubiquitin from proteins. The encoded enzyme binds to the breast cancer type 1 susceptibility protein (BRCA1) via the RING finger domain of the latter and acts as a tumor suppressor. In addition, the enzyme may be involved in regulation of transcription, regulation of cell cycle and growth, response to DNA damage and chromatin dynamics. Germline mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves increased risk of cancers including malignant mesothelioma, uveal melanoma and cutaneous melanoma.
A synthesized peptide derived from human BAP31, corresponding to a region within C-terminal amino acids.
A synthesized peptide derived from human BARD1, corresponding to a region within the internal amino acids.
A synthesized peptide derived from human BARHL2, corresponding to a region within the internal amino acids.
A synthesized peptide derived from Human BarX1.
A synthesized peptide derived from human BASP1, corresponding to a region within N-terminal amino acids.
A synthesized peptide derived from human Bassoon, corresponding to a region within C-terminal amino acids.
A synthesized peptide derived from Human BAT3.
A synthesized peptide derived from human BATF2, corresponding to a region within the internal amino acids.
Inserisci la tua e-mail e seleziona le aree di interesse per ricevere le ultime novità, approfondimenti e promozioni.
Seleziona uno o più ambiti di interesse per ricevere comunicazioni più utili e mirate.
2025 TEMA Ricerca - All Rights Reserved.
